Lilly leverages Lechleiter

Adjust font size:

Increase font size Decrease font size

Lilly leverages Lechleiter

Pharmaceutical maker Eli Lilly and Company today announced that John C. Lechleiter has been promoted to president and chief operating officer of the company and will also join the company's board of directors.

Lechleiter will assume his new responsibilities effective October 1, and will continue to report directly to Chairman and CEO Sidney Taurel. Lechleiter's new position puts him in line to potentially succeed Taurel as chairman and CEO.

“John's energy, passion, and resolve will continue to be critical assets as we work to take full advantage of our expanded product line in a cost-conscious, competitive global marketplace,” Taurel said. “This new leadership structure, which provides a balance of both strategic and operational focus, is right for this time of rapid change.”

Lechleiter earned his Ph.D. in organic chemistry from Harvard University and he joined Lilly in 1979 as a senior organic chemist. He was appointed senior vice president of pharmaceutical products at Lilly in 1998. He was promoted to executive vice president of pharmaceutical products and corporate development in 2001, assumed the role of executive vice president of pharmaceutical operations in early 2004, and then took the added responsibility for the company’s US operations later that same year.

Comments on this story

no comments yet...

click here to add a comment

You must be registered & logged in to add comments
Please register

already have an account and just want to login?

email address
password
remember me
 

Highlights

Leadership and StrategyDesign and InnovationWorld class manufacturingSkills and productivityIT in manufacturingLogistics and supply chainOperations and maintenanceEnergy business

Related Content

Boeing Celebrates the Premiere of the 787 Dreamliner
EVERETT, Wash., July 08, 2007 -- Today, Boeing...
more…